BI Asset Management Fondsmaeglerselskab’s ResMed RMD Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86M	Buy	9,551 +2,064	+28%	+$428K	0.01%	427
2026 Q1	$1.68M	Sell	7,487 -54,875	-88%	-$13.7M	0.02%	420
2025 Q4	$15M	Sell	62,362 -10,686	-15%	-$2.73M	0.13%	140
2025 Q3	$20M	Buy	73,048 +545	+0.8%	+$149K	0.18%	111
2025 Q2	$18.7M	Sell	72,503 -23,233	-24%	-$5.54M	0.18%	120
2025 Q1	$21.4M	Buy	95,736 +18,660	+24%	+$4.36M	0.24%	94
2024 Q4	$17.6M	Buy	77,076 +70,871	+1,142%	+$17.1M	0.19%	114
2024 Q3	$1.51M	Sell	6,205 -8,933	-59%	-$2M	0.03%	321
2024 Q2	$2.9M	Buy	15,138 +10,196	+206%	+$2.07M	0.05%	256
2024 Q1	$979K	Buy	4,942 +2,933	+146%	+$537K	0.02%	372
2023 Q4	$346K	Buy	2,009 +435	+28%	+$66.8K	0.01%	604
2023 Q3	$233K	Sell	1,574 -562	-26%	-$102K	0.01%	604
2023 Q2	$467K	Sell	2,136 -1,882	-47%	-$419K	0.01%	495
2023 Q1	$880K	Buy	4,018 +89	+2%	+$19.3K	0.02%	362
2022 Q4	$818K	Buy	3,929 +3,433	+692%	+$754K	0.02%	350
2022 Q3	$108K	Sell	496 -1,599	-76%	-$364K	0.01%	413
2022 Q2	$439K	Buy	+2,095	New	+$446K	0.02%	333
2020 Q4	–	Sell	-392	Closed	-$67K	–	467
2020 Q3	$67K	Buy	+392	New	+$72.4K	﹤0.01%	428

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's RMD Position: Q2 2026 in Review

BI Asset Management Fondsmaeglerselskab increased its ResMed (RMD) stake by 28% in Q2 2026, buying an estimated $428K and bringing the position to 9,551 shares worth $1.86M. The position accounts for 0.01% of the portfolio, ranked #427.

BI Asset Management Fondsmaeglerselskab first reported a position in RMD in Q3 2020 and has held it in 18 quarters since. The position peaked at $21.4M in Q1 2025. 539 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

BI Asset Management Fondsmaeglerselskab held 9,551 shares of ResMed worth $1.86M as of Q2 2026.
BI Asset Management Fondsmaeglerselskab bought 2,064 ResMed shares in Q2 2026, an estimated $428K.
ResMed made up 0.01% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #427 holding.
BI Asset Management Fondsmaeglerselskab first reported a position in ResMed in Q3 2020 and has held it in 18 quarters since.
BI Asset Management Fondsmaeglerselskab's ResMed position peaked at $21.4M in Q1 2025.
539 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.